Neuburgh Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $15K | Hold |
2,048
| – | – | ﹤0.01% | 897 |
|
|
2019
Q2 | $19K | Hold |
2,048
| – | – | ﹤0.01% | 891 |
|
|
2019
Q1 | $11K | Sell |
2,048
-400
| -16% | -$2.15K | ﹤0.01% | 899 |
|
|
2018
Q4 | $11K | Buy |
+2,448
| New | +$11K | ﹤0.01% | 881 |
|
|
2018
Q3 | – | Sell |
-27,232
| Closed | -$191K | – | 903 |
|
|
2018
Q2 | $191K | Buy |
27,232
+1,360
| +5% | +$9.54K | 0.01% | 658 |
|
|
2018
Q1 | $368K | Hold |
25,872
| – | – | 0.01% | 489 |
|
|
2017
Q4 | $227K | Sell |
25,872
-2,864
| -10% | -$25.1K | 0.01% | 623 |
|
|
2017
Q3 | $336K | Buy |
28,736
+1,808
| +7% | +$21.1K | 0.01% | 479 |
|
|
2017
Q2 | $376K | Buy |
26,928
+10,688
| +66% | +$149K | 0.01% | 441 |
|
|
2017
Q1 | $223K | Hold |
16,240
| – | – | 0.01% | 477 |
|
|
2016
Q4 | $116K | Buy |
+16,240
| New | +$116K | 0.01% | 564 |
|